A Phase 1, Open-Label Study Of The Absorption, Metabolism, And Excretion Of [14C]-Baxdrostat Following A Single Oral Dose In Healthy Male Subjects
Latest Information Update: 18 Aug 2023
At a glance
- Drugs Baxdrostat (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors AstraZeneca; CinCor Pharma
Most Recent Events
- 18 Aug 2023 Last checked against ClinicalTrials.gov record.
- 31 Jul 2023 New trial record